Alkanediols such as 1,6-hexanediol disrupt many phase-separated condensates in cellula and in vitro, but how molecular interactions are perturbed by these compounds remains unclear. This study uses ...

“It is no use asking for the impossible, such as, say, the exact wiring diagram for a cubic millimeter of brain tissue and the way all its neurons are firing,” Crick wrote in Scientific America ...

With his extreme new round of tariffs in effect as of Wednesday morning, President Trump’s trade war is at full throttle. Stock markets around the world keep plummeting, and chaos and ...

Racing toward a $1.6 billion market, the biotech stopped work on RLYB212 in a rare maternal immune disorder in response to phase 2 data. RLYB212, an anti-HPA-1a antibody, was in phase 2 ...

The Government has introduced a raft of changes to its zero emission vehicle (ZEV) mandate, with phase out dates for new petrol and diesel vans confirmed. It is ending the sale of new petrol and ...

The FDA cleared the investigational new drug application for ALX2004, with phase 1 trials expected to begin in mid-2025 for EGFR+ solid tumors. The FDA has cleared the investigational new drug (IND) ...

KUWAIT CITY, April 6: The Minister of Public Works, Dr. Noura Al-Mashaan, is set to officially sign the contract today, marking the beginning of the first phase of the Kuwait Railway Project.

An executive order from President Trump will require government agencies to make electronic payments for tax refunds, Social Security and other benefits as of Sept. 30. By Ann Carrns Paper checks ...

Roche on Thurs­day shared ear­ly pos­i­tive re­sults for its Alzheimer’s can­di­date tron­tinemab, the lat­est round of da­ta in its sec­ond at­tempt to de­vel­op a drug … ...

Though dates are not finalised, the first set of restrictions may kick into effect in Delhi, followed by five adjoining districts, and then the remaining ones. The centre may be looking to fix the ...

BeiGene is scrapping ociperlimab over a disappointing phase 3 outlook two years after Novartis handed back the anti-TIGIT antibody. The global biopharma had been evaluating ociperlimab ...